BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 297 filers reported holding BIONTECH SE in Q2 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,812,000 | – | 12,156 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,038,674 | $85,000,000 | 19.42% |
| Artal Group S.A. | 1,000,000 | $81,520,000 | 1.75% |
| PARUS FINANCE (UK) Ltd | 49,210 | $4,012,000 | 1.17% |
| Ikarian Capital, LLC | 319,900 | $26,080,000 | 1.15% |
| Parametrica Management Ltd | 18,054 | $1,473,000 | 0.91% |
| ARMISTICE CAPITAL, LLC | 236,000 | $19,239,000 | 0.65% |
| SevenBridge Financial Group, LLC | 19,013 | $1,550,000 | 0.61% |
| Redmile Group, LLC | 580,746 | $47,342,000 | 0.57% |
| Redwood Investments, LLC | 82,246 | $6,705,000 | 0.57% |
| Paradigm Financial Advisors, LLC | 24,681 | $2,012,000 | 0.54% |